Alexandria Real Estate Equities, Inc 8-K, filed Sep 30, 2009
Alexandria Real Estate Equities, Inc. (ARE)
About this 8-K
Alexandria Real Estate Equities, Inc filed this 8-K on September 30, 2009, reporting on events of September 28, 2009.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 28, 2009
ALEXANDRIA REAL ESTATE EQUITIES, INC.
(Exact name of registrant as specified in its charter)
|
Maryland |
|
1-12993 |
|
95-4502084 |
|
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
|
385 East Colorado Boulevard, Suite 299 |
|
|
|
Pasadena, California |
|
91101 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (626) 578-0777
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))
Item 8.01 Other Events
On September 28, 2009, Barclays Capital Inc., Credit Suisse Securities (USA) LLC and UBS Securities LLC, the joint bookrunning managers of the recent public offering by Alexandria Real Estate Equities, Inc. (the “Company”) of 4,000,000 shares of its common stock, exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company’s common stock at a price of $53.25 per share. The closing of the over-allotment option occurred on September 29, 2009.
The press release announcing the exercise of the over-allotment option is attached hereto as Exhibit 99.1 and is filed herewith.
The Company also hereby confirms that the issuance of additional shares pursuant to the exercise of the over-allotment option does not affect its previous guidance with respect to FFO per share (diluted) and earnings per share (diluted) set forth in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2009.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release, dated September 30, 2009
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ALEXANDRIA REAL ESTATE EQUITIES, INC. |
|
|
|
|
|
|
|
|
|
|
Date: September 30, 2009 |
By: |
/s/ Dean A. Shigenaga |
|
|
|
Dean A. Shigenaga |
|
|
|
Chief Financial Officer |
3
Exhibit 99.1
For Immediate Release
Contact: Joel S. Marcus
Chief Executive Officer
Alexandria Real Estate Equities, Inc.
(626) 578-9693
ALEXANDRIA REAL ESTATE EQUITIES, INC.
REPORTS EXERCISE OF OVER-ALLOTMENT OPTION BY UNDERWRITERS
PASADENA, CA. — September 30, 2009 - Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced today that the underwriters of its recent public offering of 4,000,000 shares of common stock have fully exercised their over-allotment option to purchase an additional 600,000 shares of common stock, bringing the total net proceeds to approximately $235 million, after payment of underwriting discounts and commissions. The closing of the over-allotment option occurred on September 29, 2009.
Barclays Capital, Credit Suisse and UBS Investment Bank acted as joint bookrunning managers of the offering.
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest owner and pre-eminent first-in-class REIT focused principally on science-driven cluster formation. Alexandria is the leading provider of high-quality environmentally sustainable real estate, technical infrastructure, and services to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biopharmaceutical, medical device, product, service and translational entities, as well as government agencies. Alexandria’s operating platform is based on the principle of “clustering,” with assets and operations located in key life science markets. As of June 30, 2009, the Company’s asset base was approximately 12.8 million rentable square feet consisting of 156 properties approximating 11.7 million rentable square feet (including spaces undergoing active redevelopment) and properties undergoing ground-up development approximating an additional 1.1 million rentable square feet.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
This press release contains forward-looking statements within the meaning of the federal securities laws. The Company’s actual results might differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in the Company’s Annual Report on Form 10-K and its other periodic reports filed with the Securities and Exchange Commission.
###